Nitecapone as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting

Annals of Thoracic Surgery

Volumn 68, Issue 2, 1999, Pages 413-420

  Vento, Antti E ^a   Aittomäki, Juha ^a   Verkkala, Kalervo A ^a   Heikkilä, Lasse J ^a   Salo, Jarmo A ^a   Sipponen, Jorma ^a   Rämö, O Juhani ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; MYELOPEROXIDASE; NITECAPONE; PLEGISOL;

ADULT; CARDIOPLEGIA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME ACTIVITY; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART PROTECTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; ISOLATED HEART; MALE; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANTIOXIDANTS; CARDIOPLEGIC SOLUTIONS; CATECHOLS; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; ENERGY METABOLISM; HEMODYNAMIC PROCESSES; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; PENTANONES; PROSPECTIVE STUDIES;

EID: 0344994539     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00514-7     Document Type: Conference Paper

References (25)

1. Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91:1872-85.
2. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991;161:488-503.
3. Sisto T, Paajanen H, Metsä-Ketelä T, Harmoinen A, Nordback I, Tarkka M. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg 1995;59:1519-23.
4. Nissinen E, Lindén IB, Pohto P. Antioxidant properties of nitecapone are potentiated by glutathione. Biochem Mol Biol Int 1995;35:387-95.
5. Marcocci L, Suzuki YJ, Tsuchiya M, Packer L. Antioxidant activity of nitecapone and its analog OR-1246: effect of structure modification on antioxidant action. Methods Enzymol 1994;234:526-41.
6. Valenza M, Serbinova E, Packer L. Nitecapone protects the Langendorff-perfused heart against ischemia-reperfusion injury. Biochem Mol Biol Int 1993;29:443-9.
7. Haramaki N, Stewart DB, Aggarwal S, Kawabata T, Packer L. Role of ascorbate in protection by nitecapone against cardiac ischemia-reperfusion injury. Biochem Pharmacol 1995;50:839-43.
8. Vento AE, Rämö OJ, Nemlander AT, Nissinen E, Holopainen A, Mattila SP. Nitecapone, a new antioxidant, has beneficial effect on functional performance in experimental heart transplantation. Res Exp Med 1997;197:137-46.
9. Vento AE, Rämö OJ, Pesonen EJ, et al. The effect of nitecapone, a new antioxidant, on myocardial function after aortic cross-clamping in experimental heart ischemia. Int J Angiol 1999;8:16-21.
10. Sundberg S, Scheinin M, Ojala-Karlsson P, Kaakkola S, Akkila J, Gordin A. Exercise hemodynamics and catecholamine metabolism after cathechol-O-methyltransferase inhibition with nitecapone. Clin Pharmacol Ther 1990;48: 356-64.
11. Suzuki K, Ota H, Sasagawa S, Sakatoni T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Ann Biochem 1983;132:345-52.
12. Laihia JK, Jansen CT, Ahotupa M. Lucigenin and linoleate enhanced chemiluminescent assay for superoxide dismutase activity. Free Radical Biol Med 1993;14:457-61.
13. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 1985;83:670-2.
14. Takada M, Ikenoya S, Yuzuhira T, Katayama K. Simultaneous determination of reduced and oxidized ubiquinones. Methods Enzymol 1985;105:147-55.
15. Vasankari T, Kujala U, Heinonen O, Kapanen J, Ahotupa M. Measurement of plasma lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. Clin Chim Acta 1995;234:63-9.
16. Uotila JT, Kirkkola AL, Rorarius M, Tuimala RJ, Metsä-Ketelä T. The total peroxyl radical-trapping ability of plasma and the cerebrospinal fluid in normal and preeclamptic parturients. Free Radical Biol Med 1994;16:581-90.
17. Toivonen HJ, Ahotupa M. Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108: 140-7.
18. Chello M, Mastroroberto P, Romano R, et al. Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting. Ann Thorac Surg 1994;58: 1427-32.
19. Taggart DP, Jenkins M, Hooper J, et al. Effects of short-term supplementation with coenzyme Q10 on myocardial protection during cardiac operations. Ann Thorac Surg 1996;61: 829-33.
20. Sunamori M, Tanaka H, Maruyama T, Sultan I, Sakamoto T, Suzuki A. Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization. Cardiovasc Drugs Ther 1991;5:297-300.
21. Ichihara T, Yasuura K, Maseki T, et al. The effects of using a leukocyte removal filter during cold blood cardioplegia. Jpn J Surg 1994;24:966-72.
22. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-51.
23. Amsterdam AA, Pan HL, Rendig SV, Symons JD, Fletcher MP, Longhurst SC. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclo-oxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration. J Am Coll Cardiol 1993;22: 1738-44.
24. Nicolini FA, Mehta JL, Nichols WW, Donnelly WH, Luostarinen R, Saldeen TGP. Leukocyte elastase inhibition and t-PA-induced coronary artery thrombosis in dogs: beneficial effects on myocardial histology. Am Heart J 1991;122: 1245-51.
25. Menasché P, Pascuier C, Bellucci S, Lorente P, Jaillon P, Piwnica A. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988;96:582-9.